ArticleBMC cardiovascular disorders2025
Physician adherence to heart failure with reduced ejection fraction treatment guidelines: a cross-sectional study in Northwest Ethiopia.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart failure is currently a major public health challenge worldwide, placing a significant burden on healthcare systems. Implementing guideline-directed medical therapies for heart failure with reduced ejection fraction is crucial to alleviating this burden; however, such practices are not optimally practiced in Ethiopia. Therefore, this study aimed to assess physicians' adherence to guideline-directed therapy for heart failure with reduced ejection fraction at Tibebe Ghion Specialized Hospital, northwest Ethiopia.
methodsAn institution-based retrospective cross-sectional study design was employed among 278 adult patients with heart failure with reduced ejection fraction who were treated at Tibebe Ghion Specialized Hospital between December 1, 2023, to January 10, 2024. Data were extracted from patients' medical records using a pre-developed checklist. Data entry was performed in EpiData version 3.1 and exported to SPSS version 25 for analysis. Descriptive statistics were computed, and an ordinal logistic regression model was used to evaluate the association between independent variables and the dependent variable.
resultsThe mean age of the study participants was 58.4 ± 14 years, and 50.4% were male. The global class adherence score was categorized as good in 70.9% of patients, moderate in 21.6%, and poor in 8%. The proportion of patients who achieved the target dose was 25.5% for ACEIs, 7.6% for BBs, and 15.8% for MRAs. Longer duration of heart failure (AOR = 0.03, 95% CI: 1.01-1.06, p < 0.023), cardiomyopathy as the underlying cause of heart failure (AOR = 3.02, 95% CI: 1.52-6.03, p < 0.002), and lower baseline LVEF (AOR = 5.28, 95% CI: 2.39-11.68, p < 0.001) were independent factors that increase physician's guideline global class adherence.
conclusionOverall, physician adherence to guideline-directed medical therapy for patients with HFrEF in this study did not address the expected AHA and ESC recommendations. Only 70.5% of patients were prescribed all the indicated drugs. Underdosing of all guideline-directed medications was observed, especially the BB dose was very suboptimal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.